- This event has passed.
Presenter(s): Gavin Bart, MD, PhD, Director, Division of Addiction Medicine at Hennepin Healthcare; Minneapolis, MN, Professor, Medical Discovery Team on Addiction at the University of Minnesota; Terry Horton, MD, Chief, Division of Addiction Medicine at Christiana Care; Wilmington, DE; Kristin Wason, MSN, NP-C, CARN, Clinical Educator, Office Based Addiction Treatment Program at Boston Medical Center and Boston University School of Medicine; Kristin Wason, MSN, NP-C, CARN, Clinical Educator, Office Based Addiction Treatment Program at Boston Medical Center and Boston University School of Medicine
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior
Cost: No fee
Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, clinical administrators and healthcare teams.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, and Interprofessional Continuing Education (IPCE) credit.
Webinar Description: Following clinical management of new and continuing patients, we need to consider how to ensure continued access to buprenorphine treatment for medically challenging patients. How do we ensure quality MOUD care for those with medical issues that may affect induction, dosing, medication choice or formulation? The session will review best practices for delivering buprenorphine to a range of patient populations, including those who are pregnant, those with acute pain and chronic pain, and those electing to taper their dose.
- Explain key considerations in managing more clinically challenging cases, including: pregnancy, surgery, pain, dose tapering
Accreditation and Certification of this activity:
In support of improving patient care, this activity has been planned and implemented by Addiction Technology Transfer Center Network and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA), Association for Social Work Boards (ASWB) and American Dental Association (ADA).
Interprofessional Continuing Education (IPCE) Designation Statement:
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.
PA Designation Statement
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.